Cardiome/Astellas' Kynapid Approval Seems Likely For Limited Indication, If Additional Trial Holds Up
This article was originally published in The Pink Sheet Daily
Executive Summary
Atrial fibrillation drug has been languishing after "approvable" letter - but approval now seems in the cards for limited indication.